scholarly journals Competing biomedical HIV prevention strategies: potential cost‐effectiveness of HIV vaccines and PrEP in Seattle, WA

2019 ◽  
Vol 22 (8) ◽  
Author(s):  
Blythe Adamson ◽  
Louis Garrison ◽  
Ruanne V Barnabas ◽  
Josh J Carlson ◽  
James Kublin ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Hiv Prevention ◽  
Prevention Strategies ◽  
Hiv Vaccines ◽  
Potential Cost ◽  
Biomedical Hiv Prevention ◽  
Hiv Prevention Strategies

Substance use patterns and awareness of biomedical HIV prevention strategies among sexual and gender minority men in Canada

AIDS Care ◽  
2020 ◽  
Vol 32 (12) ◽  
pp. 1506-1514 ◽  
Author(s):  
Kiffer G. Card ◽  
Anabelle Bernard Fournier ◽  
Justin T. Sorge ◽  
Jeffrey Morgan ◽  
Daniel Grace ◽  
...  
Keyword(s):  
Substance Use ◽  
Hiv Prevention ◽  
Prevention Strategies ◽  
Gender Minority ◽  
Use Patterns ◽  
Biomedical Hiv Prevention ◽  
Hiv Prevention Strategies ◽  
Sexual And Gender Minority ◽  
Minority Men ◽  
And Gender

Acceptability of a Dapivirine Gel Administered Rectally to HIV-1 Seronegative Adults (MTN-033 Study)

2021 ◽  
Vol 33 (5) ◽  
pp. 361-376
Author(s):  
José A. Bauermeister ◽  
Ryan C. Tingler ◽  
Sherri Johnson ◽  
Nicole Macagna ◽  
Jonathan Lucas ◽  
...  
Keyword(s):  
Hiv Prevention ◽  
Phase I ◽  
Phase I Trial ◽  
Prevention Strategies ◽  
Delivery Methods ◽  
Biomedical Hiv Prevention ◽  
Hiv Prevention Strategies ◽  
Sex With Men ◽  
Rectal Microbicide ◽  
Hiv 1

We triangulated quantitative and qualitative assessments to evaluate participants’ acceptability of 0.05% dapivirine rectal microbicide (RM) gel administered via two separate modalities (a rectal applicator and an artificial phallus for use as a coital simulation device) as part of a Phase I trial (N = 14) among men who have sex with men (MSM) randomized using a 1:1 ratio. Overall, participants reported favorable acceptability of the gel (n = 11; 78.6%), the same or more at the end of the study compared to when they started the study. Additionally, when discussing their preferred administration modality, they noted that both methods had positive qualities but also potential areas of improvement. Our findings underscore the need to create multiple delivery methods for a future microbicide gel (i.e., with and without the need for an applicator) and highlight the importance of offering MSM choices in how biomedical HIV prevention strategies are delivered.

scholarly journals Comparative costs and cost-effectiveness of behavioural interventions as part of HIV prevention strategies

2012 ◽  
Vol 28 (1) ◽  
pp. 20-29 ◽  
Author(s):  
J. Hsu ◽  
C. Zinsou ◽  
J. Parkhurst ◽  
M. N'Dour ◽  
L. Foyet ◽  
...  
Keyword(s):  
Cost Effectiveness ◽  
Hiv Prevention ◽  
Prevention Strategies ◽  
Behavioural Interventions ◽  
Hiv Prevention Strategies

Pharmacy PEP Access Intervention Among Persons Who Use Drugs in New York City: iPEPcare Study—Rethinking Biomedical HIV Prevention Strategies

2020 ◽  
Vol 24 (7) ◽  
pp. 2101-2111
Author(s):  
Crystal Fuller Lewis ◽  
Helen-Maria Lekas ◽  
Alexis Rivera ◽  
Sharifa Z. Williams ◽  
Natalie D. Crawford ◽  
...  
Keyword(s):  
New York ◽  
New York City ◽  
Hiv Prevention ◽  
York City ◽  
Prevention Strategies ◽  
Biomedical Hiv Prevention ◽  
Hiv Prevention Strategies ◽  
Persons Who Use Drugs
Sign in / Sign up

Export Citation Format

Share Document